Study ID: ABS-AS-301
Study Title
- A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromaxֲ® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Teva Identifier
- ABS-AS-301
ClinicalTrials.gov Identifier
- NCT01424813
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 12/01/2012 - 11/01/2013
Phase
- Phase 3
Study Type
Interventional
